Related Experiment Videos
[Induced leukemias and their connection with radiation exposure]
E V Domracheva1, E A Aseeva, A I Udovichenko
1National Centre for Haematology, Russian Academy of Medical Sciences, Moscow, 125167 Russia. dom@blood.ru
Radiatsionnaia Biologiia, Radioecologiia
|January 18, 2003
Summary
Secondary leukemias following cancer treatment often exhibit specific cytogenetic markers, particularly losses of chromosomes 5 and 7. These findings aid in distinguishing radiation-induced leukemias from other cases.
Area of Science:
- Cytogenetics
- Hematology
- Oncology
Context:
- Secondary leukemias arise after treatments like chemotherapy and radiotherapy for primary cancers.
- Understanding the specific genetic alterations in these secondary leukemias is crucial for diagnosis and prognosis.
- Previous studies have indicated distinct characteristics of treatment-related leukemias.
Purpose:
- To investigate the clinico-morphological and cytogenetic features of secondary leukemias.
- To identify specific chromosomal aberrations associated with secondary leukemias induced by radiation and alkylating agents.
- To differentiate between secondary and induced leukemias based on cytogenetic profiles.
Summary:
- A cytogenetic study of bone marrow cells in 40 patients with secondary leukemias revealed characteristic features.
- Losses of chromosome 5 and/or 7 were primary cytogenetic events in 60% of cases, often presenting as smoldering leukemias (M-4, M-6 variants).
- Specific chromosomal aberrations, including monosomy 5 and 7 and 11q23 rearrangements, were found in 60% of secondary leukemia cases.
Impact:
- The identified complex of cytogenetic markers can serve as a reference for radiation- or chemical-induced leukemias.
- Combining these markers with peripheral blood lymphocyte analysis can help identify radiation-induced leukemias in contaminated areas.
- The findings contribute to a clearer distinction between 'secondary' and 'induced' leukemia classifications.